Cobicistat Tablet — FDA Drug Shortage
The FDA lists a drug shortage record for Cobicistat Tablet (tablet) from Gilead Sciences, Inc. with status To Be Discontinued. The shortage was first posted on 10/07/2025.
Shortage Details
- Status
- To Be Discontinued
- Company
- Gilead Sciences, Inc.
- Package NDC
- 61958-1401-1
- Dosage Form
- Tablet
- Presentation
- Tybost, Tablet, 150 mg (NDC 61958-1401-1)
- Initial Posting
- 10/07/2025
- Revised Date